Adient Medical Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $3.5M
Latest Deal Amount
  • Investors
  • 13

Adient Medical General Information

Description

Developer of absorbable medical devices designed to prevent pulmonary embolism. The company's devices include an absorbable vascular filter with the premise that implants safe during their useful lifetime and then simply vanishes without intervention, alleviating costly removal procedures and downstream complications, enabling users to protect from a pulmonary embolism.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • 12234 Shadow Creek Parkway
  • Building 8, Suite 106
  • Pearland, TX 77584-1566
  • United States
+1 (281) 000-0000

Adient Medical Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Adient Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 24-Nov-2017 $3.5M 00.000 Completed Product Development
7. Grant 15-Apr-2017 000 00.000 Completed Pre-Clinical Trials
6. Later Stage VC (Series C) 01-Aug-2016 00.00 00.000 0000 Completed Startup
5. Accelerator/Incubator 13-Jul-2016 0000 00.000 Completed Startup
4. Early Stage VC (Series B) 11-Sep-2015 00.00 00.000 0000 Completed Startup
3. Grant 06-Mar-2015 00.00 00000 Completed Startup
2. Accelerator/Incubator 09-Mar-2015 $360K 00.00 Completed Startup
1. Early Stage VC (Series A) 05-Sep-2013 $360K $360K 00.000 Completed Startup
To view Adient Medical’s complete valuation and funding history, request access »

Adient Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 000,000 00.000000 00 00.00 00.00 00 00.00 00
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-2 300,000 $0.000100 8% $1 $1 1x $1 4.75%
Series A 200,000 $0.000100 8% $1 $1 1x $1 5.94%
To view Adient Medical’s complete cap table history, request access »

Adient Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of absorbable medical devices designed to prevent pulmonary embolism. The company's devices include an absorba
Surgical Devices
Pearland, TX
6 As of 2017
00.000
0000000000 0 00.000

0000

e cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cu
00000000 0000000
Bothell, WA
00 As of 0000
00000
0000 0000-00-00
000000&0 00000

00000000

citation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehend
000000000000000
Dublin, OH
00000 As of 0000
0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adient Medical Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
EKOS Formerly VC-backed Bothell, WA 00 00000 000000&0 00000
00000000 000000 Corporation Dublin, OH 00000 0000
To view Adient Medical’s complete competitors history, request access »

Adient Medical Executive Team (2)

Name Title Board Seat Contact Info
Mitchell Eggers Ph.D Founder, Owner, Chief Executive Officer, President & Board Member
Joseph Steele MD Chief Medical Officer
To view Adient Medical’s complete executive team members history, request access »

Adient Medical Board Members (5)

Name Representing Role Since
Maria Berkman MD Broadview Ventures Board Member 000 0000
Michael Hogan Ph.D Adient Medical Board Member 000 0000
Mitchell Eggers Ph.D Adient Medical Founder, Owner, Chief Executive Officer, President & Board Member 000 0000
Robert Mitchell Self Board Member 000 0000
Robert Tucci Texas Halo Fund Board Member 000 0000
To view Adient Medical’s complete board members history, request access »

Adient Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adient Medical Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Broadview Ventures Venture Capital Minority 000 0000 000000 0
Grant Park Ventures Venture Capital Minority 000 0000 000000 0
JF2 Capital Venture Capital Minority 000 0000 000000 0
National Heart, Lung and Blood Institute Government 000 0000 000000 0
Green Park & Golf Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »